Cargando…
The Downregulation of Opioid Receptors and Neuropathic Pain
Neuropathic pain (NP) refers to pain caused by primary or secondary damage or dysfunction of the peripheral or central nervous system, which seriously affects the physical and mental health of 7–10% of the general population. The etiology and pathogenesis of NP are complex; as such, NP has been a ho...
Autores principales: | Li, Lin, Chen, Jing, Li, Yun-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053236/ https://www.ncbi.nlm.nih.gov/pubmed/36983055 http://dx.doi.org/10.3390/ijms24065981 |
Ejemplares similares
-
Downregulation of adenosine and adenosine A1 receptor contributes to neuropathic pain in resiniferatoxin neuropathy
por: Kan, Hung-Wei, et al.
Publicado: (2018) -
Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat
por: Thompson, Scott J., et al.
Publicado: (2018) -
Targeting neuroinflammation in neuropathic pain and opioid use
por: Salvemini, Daniela, et al.
Publicado: (2022) -
The antinociceptive effects of ferulic acid on neuropathic pain: involvement of descending monoaminergic system and opioid receptors
por: Xu, Ying, et al.
Publicado: (2016) -
Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges
por: Starnowska-Sokół, Joanna, et al.
Publicado: (2020)